tiprankstipranks
Trending News
More News >
Novo Nordisk (DE:NOV)
XETRA:NOV
Germany Market

Novo Nordisk (NOV) Technical Analysis

Compare
388 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Novo Nordisk’s (NOV) Moving Averages Convergence Divergence (MACD) indicator is -0.89, suggesting Novo Nordisk is a Buy.
Novo Nordisk’s (NOV) 20-Day exponential moving average is 60.67, while Novo Nordisk’s (NOV) share price is €58.77, making it a Sell.
Novo Nordisk’s (NOV) 50-Day exponential moving average is 61.95, while Novo Nordisk’s (NOV) share price is €58.77, making it a Sell.

Novo Nordisk (NOV) Pivot Points

Jul 13, 2025, 01:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
57.71
58.52
59.82
60.63
61.93
62.74
64.04
Fibonacci
58.52
59.33
59.82
60.63
61.44
61.93
62.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novo Nordisk (NOV) Moving Averages

Jul 13, 2025, 01:46 PM
Period
Simple
Exponential
MA5
59.71Sell
59.68Sell
MA10
59.58Sell
59.91Sell
MA20
60.85Sell
60.67Sell
MA50
61.53Sell
61.95Sell
MA100
64.48Sell
66.48Sell
MA200
78.80Sell
80.46Sell
Novo Nordisk’s (NOV) 10-Day exponential moving average is 59.91, while Novo Nordisk’s (NOV) share price is €58.77, making it a Sell.
Novo Nordisk’s (NOV) 100-Day exponential moving average is 66.48, while Novo Nordisk’s (NOV) share price is €58.77, making it a Sell.
Novo Nordisk’s (NOV) stock price is €58.77 and Novo Nordisk’s (NOV) 50-day simple moving average is 61.53, creating a Sell signal.
Novo Nordisk’s (NOV) stock price is €58.77 and Novo Nordisk’s (NOV) 100-day simple moving average is 64.48, creating a Sell signal.
Novo Nordisk’s (NOV) stock price is €58.77 and Novo Nordisk’s (NOV) 200-day simple moving average is 78.80, creating a Sell signal.

Novo Nordisk (NOV) Technical Indicators

Jul 13, 2025, 01:46 PM
Name
Value
Implied Action
RSI (14)
43.28
Neutral
STOCH (9,6)
61.64
Neutral
STOCHRSI (14)
39.54
Neutral
MACD (12,26)
-0.89
Buy
ADX (14)
15.68
Buy
Williams %R
-70.55
Buy
CCI (14)
-44.62
Neutral
ATR (14)
2.07
-
Ultimate Oscillator
51.99
Neutral
ROC
-2.34
Sell
Novo Nordisk’s (NOV) Relative Strength Index (RSI) is 43.28, creating a Neutral signal.
Novo Nordisk’s (NOV) Trend Strength Indicator (ADX) is 15.68, creating a Buy signal.
Novo Nordisk’s (NOV) Commodity Channel Index (CCI) is -44.62, creating a Neutral signal.
Novo Nordisk’s (NOV) Price Rate of Change (ROC) is -2.34, creating a Sell signal.

FAQ

Is NOV a Buy, Hold, or Sell?
Based on NOV’s technical indicators, NOV is a Strong Sell.
    What is NOV’s RSI (14)?
    NOV’s RSI (14) is 43.28, which suggests NOV is a Neutral.
      What is NOV’s MACD?
      NOV’s MACD is -0.89, which suggests NOV is a Buy.
        What is NOV’s 5-day moving average?
        NOV’s 5-day moving average is 59.71, which suggests NOV is a Sell.
          What is NOV’s 20-day moving average?
          NOV 20-day moving average is 60.85, which suggests NOV is a Sell.
            What is NOV’s 50-day moving average?
            NOV’s 50-day moving average is 61.53, which suggests NOV is a Sell.
              What is NOV’s 200-day moving average?
              NOV’s 200-day moving average is 78.80, which suggests NOV is a Sell.
                What is NOV’s Williams % R (14)?
                NOV’s Williams % R (14) is -70.55, which suggests NOV is a Buy.
                  What is NOV’s CCI (14)?
                  NOV’s CCI (14) is -44.62, which suggests NOV is a Neutral.
                    What is the share price of Novo Nordisk?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis